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Abstract
This review focuses on transthoracic Doppler echocardiography as noninvasive method used to
assess coronary flow reserve (CFR) in a wide spectrum of clinical settings. Transthoracic Doppler
echocardiography is rapidly gaining appreciation as popular tool to measure CFR both in stenosed
and normal epicardial coronary arteries (predominantly in left anterior descending coronary
artery). Post-stenotic CFR measurement is helpful in: functional assessment of moderate stenosis,
detection of significant or critical stenosis, monitoring of restenosis after revascularization. In the
absence of stenosis in the epicardial coronary artery, decreased CFR enable to detect impaired
microvascular vasodilatation in: reperfused myocardial infarct, arterial hypertension with or
without left ventricular hypertrophy, diabetes mellitus, hypercholesterolemia, syndrome X,
hypertrophic cardiomyopathy. In these diseases, noninvasive transthoracic Doppler
echocardiography allows for serial CFR evaluations to explore the effect of various pharmacological
therapies.
Introduction
Coronary flow reserve (CFR) is defined as a ratio of maxi-
mal (stimulated) to baseline (resting) coronary blood
flow. CFR evaluation is important for the understanding
of the pathophysiology of coronary circulation. CFR
measurement is used both to assess epicardial coronary
stenoses and to examine the integrity of microvascular cir-
culation. An appreciation of coronary physiology is an in-
tegral part of clinical decision-making for cardiologists
treating patients with coronary artery disease. In the ab-
sence of stenosis in epicardial coronary artery, the CFR
may be decreased when coronary microvascular circula-
tion is compromised by arterial hypertension with or
without left ventricular hypertrophy, diabetes mellitus,
hypercholesterolemia, syndrome X, hypertrophic cardio-
myopathy or other diseases [1].
Methods to assess CFR
Several methods have been established for measuring CFR
(table 1). However, these methods are either invasive (in-
tracoronary Doppler flow wire), highly expensive and
scarcely available (Positron Emission Tomography) or
semi-invasive and scarcely feasible (transesophageal Dop-
pler), thus their clinical use is limited. In addition, PET
and intracoronary Doppler flow wire involve radiation ex-
posure, with inherent risk, environmental impact and bi-
ohazard connected with use of ionizing testing [2].
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Because of the clinical importance of CFR there is a need
for a simple, non-invasive, repeatable and inexpensive
tool capable of this functional evaluation. The value of ab-
solute coronary blood flow may be substituted by the val-
ue of coronary blood flow velocity [3–6] measurable by
Doppler technique not only invasively but also using a
non-invasive approach (figure 1,2,3). The present review
discusses the assessment of CFR using transthoracic Dop-
pler echocardiography, a technique which has been vali-
dated in a series of clinical studies [1,5,7–23]. Recently the
usefulness of transthoracic Doppler echocardiography to
assess CFR has been reported in various clinical settings in
a large general referral population. The method provides
reliable measurements of CFR in the distal or middle seg-
ment of left anterior descending coronary artery (LAD),
using pulsed wave Doppler echocardiography under the
guidance of color Doppler flow mapping. The develop-
ment of the transthoracic imaging technique (exploring
various transducer beam orientations) extended the possi-
bilities of imaging blood flow in the circumflex coronary
artery [1] and right coronary artery (RCA) [24–26]. As re-
gards the transthoracic Doppler assessment of CFR in the
RCA we are able to measure the coronary flow velocity in
proximal RCA and in its distal branch i.e. right posterior
descending artery. Due to the fact that most relevant RCA
stenoses are located proximal to the crux cordis the assess-
ment of CFR in the right posterior descending artery usu-
ally provide post-stenotic values. The feasibility of CFR
measurement with transthoracic Doppler echocardiogra-
phy is improved by contrast enhancement combined with
second-harmonic imaging technique. Consequently, in
some reports the feasibility of transthoracic Doppler
echocardiography to assess CFR achieved 100% [7,9].
Review
Clinical Application
There are two most relevant clinical application of tran-
sthoracic Doppler echocardiography to assess reduced
CFR due to: stenosis of epicardial LAD and impairment of
coronary microvascular vasodilatation.
Coronary angiography provides a limited insight into the
physiological significance of coronary stenoses. Therefore,
the CFR is a useful parameter in the several important
clinical setting summarized in table 2.
Functional assessment of intermediate stenosis (40–70%)
Understanding the functional impact of stenosis is impor-
tant for clinical decision making (for example to refer or
defer patients with intermediate stenosis to percutaneous
transluminal coronary angioplasty [PTCA]). The treat-
ment of patients with moderate stenoses is challenging,
and CFR measured distally to stenosis precisely defines
the hemodynamic significance of stenosis. In studies us-
ing transthoracic Doppler echocardiography, CFR <2 is as-
sociated with stress-induced ischemia [11,27] and
reduced CFR is considered as manifestation of functional-
ly important stenosis even if coronary angiography reveals
intermediate severity [7–9,16]. In contrast, in patients
with intermediate stenosis but an adequate CFR value,
PTCA can be safely deferred. The measurement of CFR by
transthoracic Doppler echocardiography provides data
equivalent to those obtained by thallium-201 scintigra-
phy for physiologic estimation of the severity of LAD ste-
nosis [11,27].
Detection of critical stenosis (>90%)
Using transthoracic Doppler echocardiography it is possi-
ble to detect severe LAD stenosis >90%. The CFR <1, sug-
gesting coronary steal may be a predictor of critical
coronary stenosis [23]. Coronary steal is defined as a de-
crease of CFR to a certain vascular region in favor of an-
other area during maximal coronary vasodilatation, that
is, CFR <1.
Combined assessment of coronary flow and wall motion
The CFR findings is additive and complementary to the in-
formation provided by 2DE on regional wall motion ab-
normalities. Combined assessment of CFR and wall
motion was performed dipyridamole echocardiographic
stress test. According to data from Rigo et al. report [28]
coronary flow and contractile function of myocardium
can be complementary in terms of predicting underlying
angiographic anatomy, because abnormal wall motion
can include coronary artery disease, and negative CFR can
exclude it. In this study, sensitivity for detecting LAD dis-
Table 1: Comparison of methods to measure CFR
Methodolgy Advantages Limitation
PET Non-invasive, global and regional CFR measurable Expensive, scarce, radiation exposure
Intra-Coronary Doppler CFR supplemented by measurement of fractional 
flow reserve provide stenosis-specific assessment
Invasive, expensive, radiation exposure
TDE Noninvasive, cheap especially without contrast 
agents,
Only regional flow velocity, mainly in the LAD is measured 
(lower feasibility of flow imaging in Cx and RCA), Difficult 
measurement of volumetric (absolute) coronary flow
PET – positron emission tomography, TDE-transthoracic Doppler echocardiographyCardiovascular Ultrasound 2003, 1 http://www.cardiovascularultrasound.com/content/1/1/4
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ease was 74% for 2-dimensional echocardiography and
81% for CFR <1.9 specificity was 91% for 2-dimensional
echocardiography and 84% for CFR. Accuracy was 86%
for 2-dimensional echocardiography and 83.5% for CFR.
When 2-dimensional echocardiography and CFR criteria
were considered, sensitivity increased to 93%, with 80.6%
specificity. The recent, ground-breaking findings of Rigo et
al [28] have already been confirmed by other studies from
Argentina [29] and Japan [30], consistently showing that
CFR, when assessed simultaneously with regional wall
motion during dipyridamole stress-echocardiography, in-
crease the sensitivity of the test, particularly in patients
who are receiving beta-blockers or in patients with single
vessel LAD disease, i.e., patients who are more likely to
have false negative tests.
Monitoring the changes of CFR in the early, post-PTCA period to de-
tect artery occlusion, microvascular stunning
Intracoronary Doppler has been introduced to optimize
the results of PTCA [31–33] but it has shown a surprising-
ly high rate of impaired CFR after balloon angioplasty or
stenting, even in the absence of any residual angiographic
stenosis [34–36]. This phenomenon may be explained by
the two following theories. Firstly, PTCA may induce mi-
crovascular stunning due to microembolization, throm-
bogenicity (by thrombin release) and vasoconstriction
(by endothelin release). Alternatively, temporary reactive
hyperemia, where high post-ischemic baseline flow veloc-
ity masks normal reserve. Invasive CFR is obtained after
multiple balloon inflations, injection of contrast agent
and administration of vasoactive drugs that may produce
immediate post-procedural vasomotion instability. For
these reasons, the measurement of CFR should be delayed
several days after PTCA. At this time, the influence of
Figure 1
Left main stem coronary artery and proximal segment of LAD in color-coded transthoracic Doppler echocardiography.Cardiovascular Ultrasound 2003, 1 http://www.cardiovascularultrasound.com/content/1/1/4
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pharmacological, metabolic, humoral or myogenic fac-
tors affecting coronary flow autoregulation is negligible,
possibly explaining the lower rate of post-procedural im-
paired CFR in a recent study using transthoracic Doppler
echocardiography [23]. The noninvasive, repeatable, inex-
pensive and accessible transthoracic Doppler echocardi-
ography is especially helpful in this clinical setting. Early
reoclussion of the coronary artery is another complication
after PTCA detectable by transthoracic Doppler
echocardiography.
Serial CFR examination after PTCA to predict restenosis
Serial CFR examination after PTCA may be also feasible in
mid- and long-term follow-up to monitor restenosis
[37,38]. The decrease of CFR <2 during follow-up was
proposed as a sensitive and specific predictor of restenosis
[37,38]. This method may be complementary to exercise
test, or may be its substitute if patients are unable to per-
form adequate exercise test.
Instead of CFR measurements distally to stenosis another
methods has been developed to detect restenosis after PT-
CA. In some patients direct imaging of the stenosis/reste-
nosis site in LAD is possible if a sufficiently long portion
of LAD is visible [39,40]. The (re)-stenotic site is identified
as localized color aliasing corresponding to local flow ac-
celeration with turbulences. It is proposed to quantify the
severity of restenosis by measuring the increase of coro-
nary blood flow velocity (ratio of pre-stenotic to stenotic
velocities) [39,40].
Postinfarction CFR assessment
There are several recent reports concerning the value of
CFR measured transthoracically after reperfused acute an-
terior myocardial infarct [41,42]. In the study of Ueno et
al. [41] the decreased CFR <1,5 was identified to predict
an increase in left ventricular volume (remodeling) after
reperfused myocardial infarct. A significant negative
correlation was found between CFR and progression of
left ventricular dilatation at 6-month follow-up. In the
Figure 2
Spectral Doppler coronary blood flow by sampling in proximal segment of LAD.Cardiovascular Ultrasound 2003, 1 http://www.cardiovascularultrasound.com/content/1/1/4
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study of Colonna et al [42] it was shown that precondi-
tioning due to preinfarction angina had a protective role
on microvascular function as demonstrated by CFR pres-
ervation (>2,5) after myocardial infarct.
Assessment of coronary graft patency
Another application of transthoracic Doppler echocardi-
ography is the assessment of the patency of internal
mammary artery and saphenous vein to coronary artery
grafts [12,43]. In the largest study [43] the identification
rate for mammary artery grafts was 100%, for saphenous
Figure 3
Direct visualization of coronary artery stenosis. The portion of mid segment of LAD with color mosaic (a sign of high-velocity, 
turbulent flow) at stenotic site.
Table 2: CRF for assessment of epicardial coronary artery stenosis
• Functional assessment of intermediate stenosis (40–70%)
• Detection of critical stenosis (>90%)
• Combined assessment of coronary flow and wall motion
• Monitoring the changes of CFR in the early, post-PTCA period to detect artery occlusion, microvascular stunning
• Serial CFR examination after PTCA to predict restenosis
• Postinfarction coronary flow reserve assessment
• Assessment of coronary graft patencyCardiovascular Ultrasound 2003, 1 http://www.cardiovascularultrasound.com/content/1/1/4
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vein grafts to LAD coronary artery 91%, for the vein grafts
to the right coronary artery 96% and for the vein grafts to
circumflex artery 90% [43]. CFR <1,9 had 100% sensitivi-
ty, 98% specificity for mammary artery graft stenosis [43].
CFR <1,6 had 91% sensitivity, 87% specificity for signifi-
cant vein graft stenosis [43].
Impairment of coronary microvascular vasodilatation
The second application of transthoracic Doppler echocar-
diography is the detection of reduced CFR due to im-
paired microvascular vasodilatation despite
angiographically normal epicardial coronary arteries. It is
well known that several diseases such as hypertrophy (due
to aortic stenosis, hypertrophic cardiomyopathy, hyper-
tension), diabetes mellitus, smoking, menopause cause
structural and/or functional abnormalities in the micro-
circulation. The invasive Doppler measurement of CFR is
not routinely performed in patients with chest pain and
normal coronary arteries. Therefore, the extent of such mi-
crovascular disease appears to be underestimated. Accord-
ingly, recent studies [4,44]. have demonstrated that up to
50% of the patients with chest pain and normal or near
normal coronary angiograms have reduced CFR. Nonin-
vasive assessment of CFR using transthoracic Doppler
echocardiography has been performed in patients with
hypertrophic cardiomyopathy [45], aortic stenosis [46]
and smokers (both active and passive) [17]. In these stud-
ies CFR was measured using adenosine (standard vasodi-
lator to test endothelium-independent vasodilatation). In
patients with hypertrophic cardiomyopathy additionally
the vasomotor response to stressors testing endothelium-
dependent vasomotion was studied [18–22,47]. Cold
pressor test [20,21], handgrip [22,47] and pacing [19] was
used as stressing stimuli. Importantly, the noninvasive ap-
proach provides an opportunity to assess asymptomatic
patients [18,20] and to recruit healthy subjects to form ad-
equate control groups [13,18,19,21,22], which is impos-
sible in an invasive study. Additionally, the effect of
physiological hypertrophy on CFR is measurable by tran-
sthoracic Doppler echocardiography [13], which could
prove useful in differentiating athlete's hypertrophic heart
– in which CFR is in normal to supranormal range – from
hypertrophic cardiomyopathy, in which CFR is markedly
attenuated.
Moreover, noninvasive transthoracic Doppler echocardi-
ography allows for serial CFR evaluations to explore the
effect of various pharmacological therapies [18] or to as-
Table 3: Proposed scheme of application of transthoracic Doppler echocardiography (with or without wall motion assessment) in 
diagnosis of epicardial or microvascular coronary vessel disease
Before coronary angiography (nondiagnostic or equivocal exercise stress ECG)
• Suspected epicardial coronary stenosis (LAD, Cx, RCA) • Suspected microvascular abnormalities
 (young patients with chest pain despite no risk factor for epicardial 
CAD)
1. WM (LV global) assessment (if negative) CFR in LAD
2. CFR (regional assessment of LAD)
After coronary angiography
Abnormal coronary angiogram Normal coronary angiogram
• Functional assessment of intermediate stenosis • Confirmation or exclusion of
 microvascular dysfunction in patients with chest pain
1. Flow acceleration at stenotic site (if not possible) CFR
2. Dual assessment of WM + CFR
Control during follow-up after initial coronary angiogram
• Patients deferred from PTCA due to intermediate stenosis • Verify the benefit of pharmacological interventions
• Patients with suspected restenosis
1. Flow acceleration at stenotic site (if not possible) CFR
2. Dual assessment of WM + CFR
WM – wall motion, LV – left ventricularCardiovascular Ultrasound 2003, 1 http://www.cardiovascularultrasound.com/content/1/1/4
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sess effect of aortic valve replacement for aortic stenosis
[19–22].
The clinical applications of CFR measurement are summa-
rized in table 3.
Choosing the appropriate stimuli
There are two pharmacological vasodilators: adenosine
and dipyridamole used to recruit CFR. Both agents are
compared in table 4. Both adenosine and dipyridamole
have an advantage over exercise and dobutamine, which
are submaximal stimuli for coronary flow reserve and are
more technically demanding for imaging of CFR [1,48].
Limitations of transthoracic Doppler echocardiography 
measurement of CFR
Absolute volumetric flow versus flow velocity
Although the left anterior descending artery was detected
with combined Doppler and two-dimensional imaging,
the images were not of sufficient clarity to allow for accu-
rate measurement of the vessel diameter in a substantial
portion of the examined subjects. Without estimation of
the coronary artery diameter we can measure changes only
in coronary blood flow velocity, but not changes in coro-
nary blood flow. Therefore CFR assessment by transtho-
racic Doppler echocardiography is limited to
measurements of coronary blood flow velocity in majority
of studies. However, it has been shown that CFR meas-
ured using both parameters is closely correlated (1–4).
Moreover, even in large invasive studies DEBATE [49] and
DESTINI [31,33] the CFR derived from changes only in
the velocity of coronary blood flow was accepted instead
of the absolute coronary blood flow, which is measurable
during invasive studies.
Regarding the accuracy of transthoracic Doppler measure-
ment of CBFV, its comparison with intracoronary meas-
urement provided a highly satisfying correlation between
non-invasive and invasive measurements [7,14].
Contrast enhancement versus non-contrast study: learning curve and 
cost-effectiveness
Another limitation is the feasibility of transthoracic coro-
nary blood flow velocity measurement. In assessment of
coronary flow in LAD, the learning curve effect was seen
in most centers in which contrast agents were not used. In
studies by Shapiro and coworkers, which were initiated in
the beginning of the 90s, the capacity of detecting coro-
nary flow increased from 34% to 77% [10,46,50,51]. Voci
and coworkers were able to increase the capacity of coro-
nary blood flow imaging from 76% [52] to 96% [23]. This
result is fully comparable with the results of studies using
contrast agents. In personal studies the capacity of detec-
tion increased with time and experience from 71% to 87%
[18,20,21]. Only Hozumi et al. [15] achieved a very high
feasibility of coronary flow imaging already in their first
study, i.e. 94%. This limitation may be minimized by us-
ing echo-contrast agents enhancing Doppler signal inten-
sity [7], which are however expensive. As regard cost-
effectiveness balance it was calculated [23] that using 90-
s noncontrast/adenosine vasodilator approach the cost of
the test was 14 times less expense than 7-min contrast-en-
hanced approach. As regard vasodilator agents, dipyrida-
mole is cheaper than adenosine and therefore the best
cost-effectiveness profile is achieved with dipyridamole
stress without contrast enhancement.
Pitfalls and trouble-shooting
CFR must be measured distally to stenosis, because erro-
neous CFR assessment at stenosis site is underestimated
due to increased baseline flow velocity. Additionally, the
flow in LAD branches could be erroneously interpreted as
the flow in LAD main trunk.
Conclusions
Transthoracic Doppler echocardiography is rapidly gain-
ing appreciation as popular tool to measure CFR both in
stenosed and normal epicardial coronary arteries (pre-
dominantly in left anterior descending coronary artery).
Post-stenotic CFR measurement is helpful in: functional
assessment of moderate stenosis, detection of significant
Table 4: Comparison between adenosine and dipyridamole
Adenosine Dipyridamole
Dosage Intravenous (i.v.) – 140 µg/kg/min Intravenous – 0,56–0,84 mg/kg
Duration of action 30 sec 30 min
Time to max. effect 30–55 sec 6–16 min
Advantage Short action, short-lasting adverse effects prolonged action allow to assess CFR and wall motion abnormalities 
during single examination
Disadvantage AV conduction delay (including complete heart 
block), Hyperventilation, hypotension, flushing, 
headache,
possibility of antidote-resistance prolonged ischemia, hypotension, 
flushing, headache, hyperventilation,Cardiovascular Ultrasound 2003, 1 http://www.cardiovascularultrasound.com/content/1/1/4
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or critical stenosis, monitoring of restenosis after revascu-
larization. In the absence of stenosis in the epicardial cor-
onary artery, decreased CFR enable to detect impaired
microvascular vasodilatation in: reperfused myocardial
infarct, arterial hypertension with or without left ventricu-
lar hypertrophy, diabetes mellitus, hypercholesterolemia,
syndrome X, hypertrophic cardiomyopathy. In these dis-
eases, noninvasive transthoracic Doppler echocardiogra-
phy allows for serial CFR evaluations to explore the effect
of various pharmacological therapies.
List of Abbreviations
CFR – coronary flow reserve
LAD – left anterior descending coronary artery
RCA – right coronary artery
PTCA – percutaneous transluminal coronary angioplasty
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